Full text
PDFPage 295
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Fleisch H. Bisphosphonates--history and experimental basis. Bone. 1987;8 (Suppl 1):S23–S28. [PubMed] [Google Scholar]
- Jodrell D. I., Iveson T. J., Smith I. E. Symptomatic hypocalcaemia after treatment with high-dose aminohydroxypropylidene diphosphonate. Lancet. 1987 Mar 14;1(8533):622–622. doi: 10.1016/s0140-6736(87)90255-8. [DOI] [PubMed] [Google Scholar]
- Keating M. J., Sethi M. R., Bodey G. P., Samaan N. A. Hypocalcemia with hypoparathyroidism and renal tubular dysfunction associated with aminoglycoside therapy. Cancer. 1977 Apr;39(4):1410–1414. doi: 10.1002/1097-0142(197704)39:4<1410::aid-cncr2820390409>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
- Papapoulos S. E., Harinck H. I., Bijvoet O. L., Gleed J. H., Fraher L. J., O'Riordan J. L. Effects of decreasing serum calcium on circulating parathyroid hormone and vitamin D metabolites in normocalcaemic and hypercalcaemic patients treated with APD. Bone Miner. 1986 Feb;1(1):69–78. [PubMed] [Google Scholar]
- Rude R. K., Oldham S. B., Singer F. R. Functional hypoparathyroidism and parathyroid hormone end-organ resistance in human magnesium deficiency. Clin Endocrinol (Oxf) 1976 May;5(3):209–224. doi: 10.1111/j.1365-2265.1976.tb01947.x. [DOI] [PubMed] [Google Scholar]